Adj A/Prof Chua Horng Ruey

Beware of Scam Calls

NUHS Institutions will NEVER ask you to transfer money or disclose bank details over a call.
If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Doctor Details

2024/03/11

Adj A/Prof Chua Horng Ruey

Designations:

Head of Division & Senior Consultant, Division of Nephrology, Department of Medicine, National University Hospital
Adjunct Associate Professor, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore

Qualifications:

MBBS (NUS), MMed (NUS), MBA (NTU), FRCP (Edinburgh), FAMS (Singapore), Fellow of American Society of Nephrology, Grad Cert (Digital Health, SMU), Certified Specialist in Renal Medicine, Singapore

Specialties/Sub-specialties:

Renal Medicine

Clinical Disciplines/Programmes:

Medicine

Special Interests:

Acute kidney injury, Urinary biomarkers, Health informatics and analytics, Continuous renal replacement therapy, Critical care nephrology, Cardio-kidney metabolic disorder, Onco-nephrology.

Make an Appointment

Find Out More:

www.nuh.com.sg/medicine

Make an Appointment

Biosketch

Adjunct Associate Professor Chua Horng Ruey earned his Bachelor of Medicine and Surgery in 2002 and his Master of Medicine (Internal Medicine) in 2007, both from the National University of Singapore. A certified Specialist in Renal Medicine since 2011, he holds fellowships with the Academy of Medicine (Singapore), the Royal College of Physicians (Edinburgh), and the American Society of Nephrology. Committed to broadening his leadership and strategic acumen, he obtained his Executive Master of Business Administration from Nanyang Technological University in 2026. He was awarded the Healthcare Manpower Development Program Award in 2010 for Critical Care Nephrology training in Australia, and the Leadership Training Award in 2025. An accomplished clinician-innovator, he received the Transition Award in 2019 for nephrotoxicity studies and the Clinician Innovator Award from the National Medical Research Council in 2024 for developing a medical device for diabetic foot screening. In 2023, he was appointed a Faculty Fellow of the Singapore Biodesign programme, reflecting his dedication to translating clinical insights into impactful healthcare innovations. His clinical interests span acute kidney injury, nephrotoxicity, urinary biomarkers, continuous renal replacement therapy, cardiorenal metabolic disorders, onconephrology, and clinical therapeutic reasoning. He is deeply committed to driving digital transformation and achieving high-quality, value-based care for kidney health management in Singapore.

Dr Chua is currently a Senior Consultant with the Division of Nephrology at the National University Hospital, where he serves as Head of Nephrology and Dialysis services, and is an Adjunct Associate Professor at the Yong Loo Lin School of Medicine, National University of Singapore.

Journals & Publications

Selected publications

Chua HR, Low S, Murali TM, Wong ET, He HD, Teo BW, Thian YL, Akalya K, Vathsala A.
Cumulative iodinated contrast exposure for computed tomography during acute kidney injury and major adverse kidney events.
European Radiology. 2020 Nov 7. Online.
Chua HR, MacLaren G, Choong LH, Chionh CY, Khoo BZE, Yeo SC, Sewa DW, Ng SY, Choo JC, Teo BW, Tan HK, Siow WT, Agrawal RV, Tan CS, Vathsala A, Tagore R, Seow TY, Khatri P, Hong WZ, Kaushik M.
Ensuring sustainability of continuous kidney replacement therapy in the face of extraordinary demand: Lessons from the COVID-19 pandemic.
Journal of Kidney Diseases. 2020; 76(3):392-400.
Low S, Vathsala A, Murali TM, Pang L, MacLaren G, Ng WY, Haroon S, Mukhopadhyay A, Lim SL, Tan BH, Lau T, Chua HR.
Electronic health records accurately predict renal replacement therapy in acute kidney injury.
Nephrology. 2019 Jan 31;20(1):32.
Chua HR, Wong WK, Ong VH, Agrawal D, Vathsala A, Tay HM, Mukhopadhyay A.
Extended mortality and chronic kidney disease after septic acute kidney injury.
Journal of Intensive Care Med. 2020 Jun;35(6):527-535.
Da Y, Akalya K, Murali T, Vathsala A, Tan CS, Low S, Lim HN, Teo BW, Lau T, Ong L, Chua HR.
Serial Quantification of Urinary Protein Biomarkers to Predict Drug-induced Acute Kidney Injury.
Current Drug Metabolism. 2019;20(8):656-664.
Tan JN, Haroon SW, Mukhopadhyay A, Lau T, Murali TM, Phua J, Tan ZY, Lee N, Chua HR.
Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
Journal of Intensive Care Med. 2019; 34(5):418-25.
Ong LZ, Tambyah PA, Lum LH, Low ZJ, Cheng I, Murali TM, Wan MQ, Chua HR.
Aminoglycoside-associated acute kidney injury in elderly patients with and without shock.
Journal of Antimicrobial Chemotherapy. 2016 Nov;71(11):3250-3257.
Chua HR, Schneider AG, Sherry NL, Lotfy N, Chan MJ, Galtieri J, Wong GR, Lipcsey M, Matte CD, Collins A, Garcia-Alvarez M, Bellomo R.
Initial and Extended Use of Femoral Versus Nonfemoral Double-Lumen Vascular Catheters and Catheter-Related Infection During Continuous Renal Replacement Therapy.
American Journal of Kidney Diseases. 2014; 64(6):909-17.

2026/06/26